Cardiva Medical logo

Cardiva Medical Funding & Investors

Cardiva Medical is a rapidly growing medical device company that designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional cardiovascular procedures. Our latest advancement is the VASCADE® Vascular Closure System. VASCADE is SAFE. SIMPLE. GUARANTEED. In the Level 1 prospective, multi-center, randomized clinical trial called RESPECT (Hermiller et al), VASCADE was proven safer than manual compression and demonstrated ZERO(0) major complications. VASCADE is elegantly SIMPLE and provides both mechanical as well as physiologic hemostasis with ~13X expansion of collagen when hydrated, utilizing extravascular bioabsorbable collagen VASCADE is GUARANTEED. Because Cardiva Medical® is so committed and confident in VASCADE®’s ability to safely and rapidly achieve hemostasis, we offer a unique value-based purchasing program called the VASCADE® Performance Guarantee. In the event of a complication as the result of VASCADE, Cardiva Medical will provide significant financial reimbursement to your hospital or practice. It’s simple, we’re dedicated to exceptional outcomes for you and your patients. We stand behind our product based upon published clinical studies and demonstrated superior performance in the surgical theater.

cardivamedical.com

Total Amount Raised: $177,740,000

Cardiva Medical Funding Rounds

  • Debt Financing

    $11,000,000

    Debt Financing Investors

    PTV Healthcare Capital
    Luther King Capital Management
    Evidity Health Capital
  • Series Unknown

    $16,500,000

    Series Unknown Investors

    Evidity Health Capital
    PTV Healthcare Capital
    Amkey Ventures
    Triventures
  • Series D

    $15,500,000

    Series D Investors

    Galen Partners
    PTV Healthcare Capital
    Sycamore Ventures
    Amkey Ventures
    Eminent Venture Capital
  • Series C

    $13,990,000

    Series C Investors

    Galen Partners
    Stockton & Partners
    Sycamore Ventures
    Harbinger Venture
    WI Harper Group
    Amkey Ventures
  • Series B

    $8,300,000

    Series B Investors

    Stockton & Partners
    Sycamore Ventures
    Harbinger Venture
    WI Harper Group
  • Series A

    $10,500,000

    Series A Investors

    WI Harper Group
    Harbinger Venture
    Sycamore Ventures
  • Series Unknown

    $45,000,000

    Series Unknown Investors

    Essex Woodlands
  • Series Unknown

    $30,000,000

    Series Unknown Investors

    PTV Healthcare Capital
    Evidity Health Capital
  • Debt Financing

    $12,500,000

    Debt Financing Investors

    GE Capital
  • Series Unknown

    $7,450,000

    Series Unknown Investors

    PTV Healthcare Capital
    Galen Partners
    Sycamore Ventures
    Amkey Ventures
  • Series A

    $7,000,000

    Series A Investors

    Sycamore Ventures
    Harbinger Venture
    WI Harper Group
Funding info provided by Diffbot.